Quest Diagnostics (DGX) to Acquire Haystack Oncology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. KNX
10. KMI

Go back to Quest Diagnostics (DGX) to Acquire Haystack Oncology

Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio

April 27, 2023 6:34 AM EDT

Goal to improve patient outcomes through early, accurate detection of residual or recurring cancer

Haystack's highly sensitive minimal-residual disease cancer-detection technology to be combined with Quest's oncology, genomics and pathology expertise and scale, including solid tumor sequencing, convenient specimen collection and EHR connectivity

SECAUCUS, N.J. and BALTIMORE, April 27, 2023 /PRNewswire/ --... More